Biopharma | May 08, 2026
Biocon Q4 profit jumps 64%; FY26 revenue crosses Rs. 16,900 crore
The biosimilars business generated Rs. 10,431 crore in FY26 revenue, up 16% year-on-year
The biosimilars business generated Rs. 10,431 crore in FY26 revenue, up 16% year-on-year
Clinical guidelines and expert consensus recommend 1.2–1.5 g/kg/day protein intake during therapy to help preserve muscle mass
U.S. business drives strong growth as Lupin reports 57% rise in Q4 U.S. sales and 43% increase in gross profit
Hair care & quick commerce shine
The leading cancer hospital urges carrier screening to prevent thalassemia burden
The partnership will focus on diabetes and NCD awareness, rare disease screening, and deployment of mobile medical units
The facility combines advanced diagnostics, bone marrow transplant evaluation, prenatal awareness, and multidisciplinary support services
The deal brings SAI — a key distributor serving pharmaceutical and nutraceutical manufacturers — into the Safic-Alcan Group’s expanding Asia footprint
The 40-second film brings children to the forefront of the narrative
Supported by Plan International, the partnership will help treat over 1,000 children annually
Subscribe To Our Newsletter & Stay Updated
